← Leaderboards
Hon Wai Koon
University Of California Los Angeles
$2,729,371
Attributed
$2,729,371
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $375.1K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,729,371 · 4
By mechanism
R01$1,403,285 · 1
K01$743,086 · 1
R21$429,000 · 1
R03$154,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Sinisa Dovat$7,191,819
- Sang Hoon Rhee$1,319,973
- Eunok Im$449,557
- Alexander M Cole$10,641,954
- Xiaochun Yu$9,555,119
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingAnti-Inflammatory AgentsOverexpressionColitisTissuesMouse ModelEnvironmentFibrosisReportingAnimal ModelFibroblastsLiteratureInfectionPublic Health RelevanceIntestinesCathelicidinFutureColonBaseCellsImmune ResponseIn VivoAnti-InflammatoryAntibiotics
Grant awards (13)
Oral elafin formulation for intestinal fibrosis$323,516
R01 · FY2025 · DK · contact PI
Oral elafin formulation for intestinal fibrosis$345,117
R01 · FY2024 · DK · contact PI
Oral elafin formulation for intestinal fibrosis$359,522
R01 · FY2023 · DK · contact PI
Oral elafin formulation for intestinal fibrosis$375,130
R01 · FY2022 · DK · contact PI
Orally active metabolite therapy against C. difficile infection$234,000
R21 · FY2020 · AI · contact PI
Orally active metabolite therapy against C. difficile infection$195,000
R21 · FY2019 · AI · contact PI
Role of Cathelicidin in Obesity and Diabetes$77,000
R03 · FY2016 · DK · contact PI
Role of Cathelicidin in Obesity and Diabetes$77,000
R03 · FY2015 · DK · contact PI
Role of Cathelicidin in Intestinal Inflammation$143,925
K01 · FY2014 · DK · contact PI
Role of Cathelicidin in Intestinal Inflammation$146,572
K01 · FY2013 · DK · contact PI
Role of Cathelicidin in Intestinal Inflammation$149,167
K01 · FY2012 · DK · contact PI
Role of Cathelicidin in Intestinal Inflammation$151,711
K01 · FY2011 · DK · contact PI
Role of Cathelicidin in Intestinal Inflammation$151,711
K01 · FY2010 · DK · contact PI